 Kidney Failure, Chronic
"Kidney Failure, Chronic" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION.
| Descriptor ID |
D007676
|
| MeSH Number(s) |
C12.777.419.780.750.500 C13.351.968.419.780.750.500
|
| Concept/Terms |
Kidney Failure, Chronic- Kidney Failure, Chronic
- End-Stage Kidney Disease
- Disease, End-Stage Kidney
- End Stage Kidney Disease
- Kidney Disease, End-Stage
- Chronic Kidney Failure
- End-Stage Renal Disease
- Disease, End-Stage Renal
- End Stage Renal Disease
- Renal Disease, End-Stage
- Renal Disease, End Stage
- Renal Failure, End-Stage
- End-Stage Renal Failure
- Renal Failure, End Stage
- Renal Failure, Chronic
- Chronic Renal Failure
- ESRD
|
Below are MeSH descriptors whose meaning is more general than "Kidney Failure, Chronic".
Below are MeSH descriptors whose meaning is more specific than "Kidney Failure, Chronic".
This graph shows the total number of publications written about "Kidney Failure, Chronic" by people in this website by year, and whether "Kidney Failure, Chronic" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 3 | 1 | 4 | | 1996 | 0 | 2 | 2 | | 1997 | 2 | 0 | 2 | | 1999 | 2 | 1 | 3 | | 2000 | 2 | 1 | 3 | | 2001 | 1 | 2 | 3 | | 2002 | 3 | 1 | 4 | | 2003 | 9 | 1 | 10 | | 2004 | 3 | 6 | 9 | | 2005 | 8 | 10 | 18 | | 2006 | 8 | 0 | 8 | | 2007 | 9 | 5 | 14 | | 2008 | 12 | 6 | 18 | | 2009 | 18 | 1 | 19 | | 2010 | 17 | 4 | 21 | | 2011 | 15 | 8 | 23 | | 2012 | 12 | 5 | 17 | | 2013 | 14 | 3 | 17 | | 2014 | 14 | 4 | 18 | | 2015 | 20 | 2 | 22 | | 2016 | 18 | 5 | 23 | | 2017 | 21 | 4 | 25 | | 2018 | 17 | 8 | 25 | | 2019 | 13 | 1 | 14 | | 2020 | 21 | 4 | 25 | | 2021 | 14 | 3 | 17 | | 2022 | 10 | 0 | 10 | | 2023 | 17 | 2 | 19 | | 2024 | 4 | 3 | 7 | | 2025 | 12 | 0 | 12 |
To return to the timeline, click here.
Below are the most recent publications written about "Kidney Failure, Chronic" by people in Profiles.
-
Husain SA, Maclay LM, Yu M, Amaral S, McAteer J, Potluri V, Schold JD, Mohan S. Consent to Receive Offers for Kidneys From Donors With Hepatitis C Among Pediatric Kidney Transplant Candidates in the United States. Pediatr Transplant. 2025 Nov; 29(7):e70167.
-
Bunnapradist S, Leca N, Zaky ZS, Stratta RJ, Khamash HA, Shihab F, Ekwenna O, Aldana-Campos M, Kahwaji J, Biancone L, Maw TT, Biagini DG, Kaur N, Prewett A, Gude G, Van Hummelen P, Bloom MS, Demko Z, Rabinowitz M, Chapman SL, Gauthier P, Bhorade S, Tabriziani H, Qazi Y. Associations between donor-derived cell-free DNA dynamics and clinical outcomes after kidney allograft rejection: A prospective, multicenter study. Am J Transplant. 2025 Dec; 25(12):2543-2553.
-
Dixon A, Pruette C, Ranch D, Raina R, Ferris M, Shih WV. Transitioning from pediatric- to adult-focused dialysis care: A systematic review with recommendations. Clin Nephrol. 2025 Jul; 104(1):34-45.
-
Di Napoli M, Rouhi AD, Baimas-George M, Dumon K, Castle R, Kennealey P, Nydam T, Choudhury R. Sleeve gastrectomy versus dual GLP-1/GIP receptor agonist to improve access to kidney transplantation in patients with end-stage renal disease and obesity: A decision analysis. Am J Surg. 2025 Dec; 250:116475.
-
Petr V, Tichanek F, Liu SL, Poppelaars F, Renner B, Laskowski J, Purohit S, Zhao M, Jalal D, Heeger PS, Thurman JM. Pretransplant natural antibody levels identify a subset of deceased donor kidney transplant recipients that benefit from infliximab induction. Am J Transplant. 2025 Oct; 25(10):2173-2181.
-
Rizzolo K, Villegas L, Cervantes L. The national landscape of kidney transplantation for undocumented immigrants: advancing kidney transplantation equity. Kidney Int. 2025 Jun; 107(6):976-979.
-
Foulon N, Haeger SM, Okamura K, He Z, Park BD, Budnick IM, Madison D, Kennis M, Blaine R, Miyazaki M, Jalal DI, Griffin BR, Aftab M, Colbert JF, Faubel S. Procalcitonin levels in septic and nonseptic subjects with AKI and ESKD prior to and during continuous kidney replacement therapy (CKRT). Crit Care. 2025 Apr 30; 29(1):171.
-
Di Napoli M, Rouhi AD, Dumon KR, Castle R, Williams NN, Baimas-George M, Kennealey PT, Nydam TL, Choudhury RA. Sleeve gastrectomy versus GLP-1 agonist to improve kidney transplant access in end-stage renal disease patients with obesity: a decision analysis. Surg Obes Relat Dis. 2025 08; 21(8):921-928.
-
Teitelbaum I, Zhao J, Tu C, Bieber B, Davies S, Johnson DW, Kawanishi H, Kim YL, Kanjanabuch T, Pisoni RL, Perl J. Associations Between Serum Sodium, Peritoneal Dialysis-Associated Peritonitis, and Mortality in the Peritoneal Dialysis Outcomes and Practice Patterns Study (PDOPPS). Am J Kidney Dis. 2025 Jul; 86(1):84-96.e1.
-
Ahmed S, Pfeiffer RM, Volesky-Avellaneda K, Blosser CD, Snyder JJ, Israni AK, Lynch CF, Qiao B, Rees JR, Zwald F, Yu KJ, Engels EA. Real-world evidence regarding cancer, mortality, and graft failure risk with de novo belatacept use among kidney transplant recipients in the United States. Am J Transplant. 2025 Aug; 25(8):1723-1734.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|